PI11653 10-Bromodecanoic acid (CAS No.: 50530-12-6)

10-Bromodecanoic acid (CAS No.: 50530-12-6) Description

10-Bromodecanoic acid, with the chemical formula C10H19BrO2, is a brominated derivative of decanoic acid used in pharmaceutical synthesis. The bromine substituent alters its reactivity, facilitating specific transformation pathways during intermediate synthesis. Its defined chemical structure enables predictable performance in subsequent reactions, offering enhanced control in molecular modifications. This compound's consistent composition supports precise formulation in active pharmaceutical ingredient development.

10-Bromodecanoic acid (CAS No.: 50530-12-6) Applications

1.         Pharmaceutical Synthesis
- Used as a reactive intermediate in API production to achieve targeted molecular modifications by leveraging its bromine-induced reactivity, which optimises reaction selectivity.

2.         Organic Synthesis Research
- Applied as a derivatisation agent in synthetic protocols to promote efficient reaction pathways via its predictable chemical behaviour, aiding experimental reproducibility.

3.         Analytical Chemistry
- Serves as a calibration standard in chromatographic techniques to address issues of measurement accuracy by utilising its consistent chemical properties.

10-Bromodecanoic acid (CAS No.: 50530-12-6) Packing

10-Bromodecanoic acid is packaged in sealed, moisture-resistant containers with a secondary protective overwrap to minimise exposure to contaminants. Hard plastic or glass vessels are used to prevent mechanical damage. The packaging design incorporates anti-static measures and is suitable for temperature-controlled storage. Custom packaging options are available, including bulk and small-scale solutions, to meet specific handling requirements.

Additional Information

Halogenated fatty acids serve as key intermediates in pharmaceutical and organic synthesis. Their structural attributes demand precise production and control to ensure reliable reactivity during chemical transformations. Factors such as chain length and the presence of a bromine substituent play a crucial role in determining both stability and reaction behaviour.

Understanding the reactivity and handling of such compounds contributes to broader advancements in medicinal chemistry and process development. Researchers and engineers are encouraged to consider both operational protocols and material characteristics when integrating these intermediates into synthesis workflows.